Pneumocystis pneumonia, a (major) opportunistic infection in immunocompromised patients, is caused by the fungus Pneumocystis jirovecii (P. jirovecii). The incidence of Pneumocystis pneumonia, which increased dramatically with the advent of the HIV/AIDS pandemic, has decreased in the industrialized world owing to the widespread use of sulfa drug prophylaxis and the introduction of highly active antiretroviral therapy (HAART). However, P. jirovecii remains an important cause of morbidity and mortality in HIV/AIDS patients, as well as in non-HIV immunocompromised patients, in whom its diagnosis is difficult.
“Targets
• Pneumocystis jirovecii
• DHPS mutations (codon 55 and 57)
• Internal Control (IC)
• Quantification standards:
• Standard 1: 10000 copies/μl
• Standard 2: 1000 copies/μl
• Standard 3: 100 copies/μl
• Standard 4: 10 copies/μl
